Monday, June 2, 2014

GSK in $350 million deal to develop cancer drugs with UK biotech firm

Retweeted Medical News (@MedicalNews): GSK in $350 million deal to develop cancer drugs with UK biotech firm http://t.co/plF5omjwfn

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/plF5omjwfn

No comments:

Post a Comment